Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 371

1.

Evolving management of ST-segment elevation myocardial infarction: update on recent data.

Cannon CP.

Am J Cardiol. 2006 Dec 18;98(12A):10Q-21Q. Epub 2006 Nov 7. Review.

PMID:
17169625
[PubMed - indexed for MEDLINE]
2.

New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines.

Spinler SA, Hilleman DE, Cheng JW, Howard PA, Mauro VF, Lopez LM, Munger MA, Gardner SF, Nappi JM.

Ann Pharmacother. 2001 May;35(5):589-617. Review.

PMID:
11346067
[PubMed - indexed for MEDLINE]
3.

2007 Guideline update for unstable angina/non-ST-segment elevation myocardial infarction: focus on antiplatelet and anticoagulant therapies.

Coons JC, Battistone S.

Ann Pharmacother. 2008 Jul;42(7):989-1001. doi: 10.1345/aph.1L063. Epub 2008 Jun 24.

PMID:
18577763
[PubMed - indexed for MEDLINE]
4.

Managing acute coronary syndrome: evidence-based approaches.

Spinler SA.

Am J Health Syst Pharm. 2007 Jun 1;64(11 Suppl 7):S14-24.

PMID:
17519441
[PubMed - indexed for MEDLINE]
5.

Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel, or both?

Silva MA, Donovan JL, Gandhi PJ, Volturo GA.

Vasc Health Risk Manag. 2006;2(1):39-48. Review.

PMID:
17319468
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Low-molecular-weight heparin compared with unfractionated heparin for patients with non-ST-segment elevation acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE initiative.

Singh KP, Roe MT, Peterson ED, Chen AY, Mahaffey KW, Goodman SG, Harrington RA, Smith SC Jr, Gibler WB, Ohman EM, Pollack CV Jr; CRUSADE Investigators.

J Thromb Thrombolysis. 2006 Jun;21(3):211-20.

PMID:
16683212
[PubMed - indexed for MEDLINE]
7.

What anti-thrombotic therapy is best with primary PCI for acute ST elevation myocardial infarction: how should the HORIZONS trial change current practice?

Brodie BR.

Catheter Cardiovasc Interv. 2008 May 1;71(6):816-21. doi: 10.1002/ccd.21518.

PMID:
18412079
[PubMed - indexed for MEDLINE]
8.

2007 focused update to the ACC/AHA guidelines for the management of patients with ST-segment elevation myocardial infarction: implications for emergency department practice.

Pollack CV Jr, Antman EM, Hollander JE; American College of Cardiology; American Heart Association.

Ann Emerg Med. 2008 Oct;52(4):344-355.e1. doi: 10.1016/j.annemergmed.2008.04.004. Epub 2008 Jun 2.

PMID:
18519158
[PubMed - indexed for MEDLINE]
9.

Efficacy and safety of enoxaparin versus unfractionated heparin in patients with ST-segment elevation myocardial infarction also treated with clopidogrel.

Sabatine MS, Morrow DA, Dalby A, Pfisterer M, Duris T, Lopez-Sendon J, Murphy SA, Gao R, Antman EM, Braunwald E; ExTRACT-TIMI 25 Investigators.

J Am Coll Cardiol. 2007 Jun 12;49(23):2256-63. Epub 2007 May 25.

PMID:
17560290
[PubMed - indexed for MEDLINE]
Free Article
10.

Evolving antithrombotic treatment strategies for acute ST-elevation myocardial infarction.

Kandzari DE.

Rev Cardiovasc Med. 2006;7 Suppl 4:S29-37. Review.

PMID:
17224888
[PubMed - indexed for MEDLINE]
11.

Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Harrington RA, Becker RC, Cannon CP, Gutterman D, Lincoff AM, Popma JJ, Steg G, Guyatt GH, Goodman SG; American College of Chest Physicians.

Chest. 2008 Jun;133(6 Suppl):670S-707S. doi: 10.1378/chest.08-0691.

PMID:
18574276
[PubMed - indexed for MEDLINE]
12.

Clinical update on the therapeutic use of clopidogrel: treatment of acute ST-segment elevation myocardial infarction (STEMI).

Tran H, Mehta SR, Eikelboom JW.

Vasc Health Risk Manag. 2006;2(4):379-87. Review.

PMID:
17323592
[PubMed - indexed for MEDLINE]
Free PMC Article
13.
14.

Acute myocardial infarction 2000 treatment.

Wehrmacher WH.

Compr Ther. 2001 Fall;27(3):228-31.

PMID:
11569324
[PubMed - indexed for MEDLINE]
15.

Use of low-molecular-weight heparins in the management of acute coronary artery syndromes and percutaneous coronary intervention.

Wong GC, Giugliano RP, Antman EM.

JAMA. 2003 Jan 15;289(3):331-42. Review.

PMID:
12525234
[PubMed - indexed for MEDLINE]
16.

Patterns of upstream antiplatelet therapy use before primary percutaneous coronary intervention for acute ST-elevation myocardial infarction (from the CRUSADE National Quality Improvement Initiative).

Alexander D, Mann N, Ou FS, Peterson ED, Ohman EM, Gibler WB, Roe MT.

Am J Cardiol. 2008 Nov 15;102(10):1335-40. doi: 10.1016/j.amjcard.2008.06.063. Epub 2008 Sep 6.

PMID:
18993151
[PubMed - indexed for MEDLINE]
17.

An analysis of the Association of Society of Chest Pain Centers Accreditation to American College of Cardiology/American Heart Association non-ST-segment elevation myocardial infarction guideline adherence.

Chandra A, Glickman SW, Ou FS, Peacock WF, McCord JK, Cairns CB, Peterson ED, Ohman EM, Gibler WB, Roe MT.

Ann Emerg Med. 2009 Jul;54(1):17-25. doi: 10.1016/j.annemergmed.2009.01.025. Epub 2009 Mar 12.

PMID:
19282062
[PubMed - indexed for MEDLINE]
18.

Antithrombotic therapy and the transition to the catheterization laboratory in UA/NSTEMI.

Ferguson JJ, Wilson JM, Diez J.

Minerva Cardioangiol. 2007 Oct;55(5):529-56. Review.

PMID:
17912162
[PubMed - indexed for MEDLINE]
20.

Appropriate antiplatelet and antithrombotic therapy in patients with acute coronary syndromes: recent updates to the ACC/AHA guidelines.

Mehta SR; ACC/AHA.

J Invasive Cardiol. 2002 Dec;14 Suppl E:27E-34E; quiz 35E. Review.

PMID:
12668860
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk